| 注册
首页|期刊导航|中国药业|雾化吸入糖皮质激素用于长期控制不佳的老年哮喘疗效分析

雾化吸入糖皮质激素用于长期控制不佳的老年哮喘疗效分析

钟兴峰

中国药业2017,Vol.26Issue(10):54-56,3.
中国药业2017,Vol.26Issue(10):54-56,3.DOI:10.3969/j.issn.1006-4931.2017.10.015

雾化吸入糖皮质激素用于长期控制不佳的老年哮喘疗效分析

Clinical Efficacy of Atomizing Inhaled Glucocorticoid in Elderly Patients with Poor Long-Term Asthma Control

钟兴峰1

作者信息

  • 1. 湖北省麻城市人民医院呼吸内科,湖北黄冈 438000
  • 折叠

摘要

Abstract

Objective To analyze clinical efficacy of atomizing inhaled glucocorticoid in elderly patients with poor long-term asthma control. Methods Totally 98 elderly patients with asthma in our hospital from July 2014 to July 2016 were randomly divided into the experimental group and the control group,49 cases in each group. The experimental group was taken atomizing inhaled glucocorticoid,the control group was treated with conventional method. The therapeutic effect and adverse reactions in the two groups were compared. Results The peak expiratory flow rate of the experimental group was significantly better than that of the control group (P < 0. 05),the ACT scores of the experimental group was significantly higher than that of the control group ( P < 0. 05 ) ,the adverse reactions in the two groups had significant difference(P < 0. 05). Conclusion The clinical efficacy of atomizing inhaled glucocorticoid in elderly patients with poor long-term asthma control is good,it is safe and worthy of clinical promotion.

关键词

雾化吸入/糖皮质激素/哮喘/老年/临床疗效

Key words

aerosol inhalation/glucocorticoid/asthma/elderly/clinical effect

分类

医药卫生

引用本文复制引用

钟兴峰..雾化吸入糖皮质激素用于长期控制不佳的老年哮喘疗效分析[J].中国药业,2017,26(10):54-56,3.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文